A citation-based method for searching scientific literature

Carlos F Ibáñez. Cold Spring Harb Perspect Biol 2013
Times Cited: 98







List of co-cited articles
1130 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The GDNF family: signalling, biological functions and therapeutic value.
Matti S Airaksinen, Mart Saarma. Nat Rev Neurosci 2002
24

Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret.
A Schuchardt, V D'Agati, L Larsson-Blomberg, F Costantini, V Pachnis. Nature 1994
21

RET tyrosine kinase signaling in development and cancer.
Elena Arighi, Maria Grazia Borrello, Hannu Sariola. Cytokine Growth Factor Rev 2005
306
20

KIF5B-RET fusions in lung adenocarcinoma.
Takashi Kohno, Hitoshi Ichikawa, Yasushi Totoki, Kazuki Yasuda, Masaki Hiramoto, Takao Nammo, Hiromi Sakamoto, Koji Tsuta, Koh Furuta, Yoko Shimada,[...]. Nat Med 2012
570
19

GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF.
S Jing, D Wen, Y Yu, P L Holst, Y Luo, M Fang, R Tamir, L Antonio, Z Hu, R Cupples,[...]. Cell 1996
990
19

RET revisited: expanding the oncogenic portfolio.
Lois M Mulligan. Nat Rev Cancer 2014
293
19

A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.
Cristina Romei, Raffaele Ciampi, Rossella Elisei. Nat Rev Endocrinol 2016
162
17

Structure and chemical inhibition of the RET tyrosine kinase domain.
Phillip P Knowles, Judith Murray-Rust, Svend Kjaer, Rizaldy P Scott, Sarah Hanrahan, Massimo Santoro, Carlos F Ibáñez, Neil Q McDonald. J Biol Chem 2006
174
16

RET, ROS1 and ALK fusions in lung cancer.
Kengo Takeuchi, Manabu Soda, Yuki Togashi, Ritsuro Suzuki, Seiji Sakata, Satoko Hatano, Reimi Asaka, Wakako Hamanaka, Hironori Ninomiya, Hirofumi Uehara,[...]. Nat Med 2012
896
15

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli,[...]. J Clin Oncol 2012
849
15

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.
L M Mulligan, J B Kwok, C S Healey, M J Elsdon, C Eng, E Gardner, D R Love, S E Mole, J K Moore, L Papi. Nature 1993
15

Characterization of a multicomponent receptor for GDNF.
J J Treanor, L Goodman, F de Sauvage, D M Stone, K T Poulsen, C D Beck, C Gray, M P Armanini, R A Pollock, F Hefti,[...]. Nature 1996
921
15

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.
L F Lin, D H Doherty, J D Lile, S Bektesh, F Collins. Science 1993
15

RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients.
Shumei Kato, Vivek Subbiah, Erica Marchlik, Sheryl K Elkin, Jennifer L Carter, Razelle Kurzrock. Clin Cancer Res 2017
113
15

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.
Doron Lipson, Marzia Capelletti, Roman Yelensky, Geoff Otto, Alex Parker, Mirna Jarosz, John A Curran, Sohail Balasubramanian, Troy Bloom, Kristina W Brennan,[...]. Nat Med 2012
615
14

GDNF signalling through the Ret receptor tyrosine kinase.
P Durbec, C V Marcos-Gutierrez, C Kilkenny, M Grigoriou, K Wartiowaara, P Suvanto, D Smith, B Ponder, F Costantini, M Saarma. Nature 1996
679
14

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.
M Grieco, M Santoro, M T Berlingieri, R M Melillo, R Donghi, I Bongarzone, M A Pierotti, G Della Porta, A Fusco, G Vecchio. Cell 1990
817
14

Functional receptor for GDNF encoded by the c-ret proto-oncogene.
M Trupp, E Arenas, M Fainzilber, A S Nilsson, B A Sieber, M Grigoriou, C Kilkenny, E Salazar-Grueso, V Pachnis, U Arumäe. Nature 1996
681
14

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015
929
14

Selective RET kinase inhibition for patients with RET-altered cancers.
V Subbiah, V Velcheti, B B Tuch, K Ebata, N L Busaidy, M E Cabanillas, L J Wirth, S Stock, S Smith, V Lauriault,[...]. Ann Oncol 2018
186
14

Cabozantinib in progressive medullary thyroid cancer.
Rossella Elisei, Martin J Schlumberger, Stefan P Müller, Patrick Schöffski, Marcia S Brose, Manisha H Shah, Lisa Licitra, Barbara Jarzab, Viktor Medvedev, Michael C Kreissl,[...]. J Clin Oncol 2013
658
13


Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex.
R H Baloh, M G Tansey, P A Lampe, T J Fahrner, H Enomoto, K S Simburger, M L Leitner, T Araki, E M Johnson, J Milbrandt. Neuron 1998
453
13

RET recognition of GDNF-GFRα1 ligand by a composite binding site promotes membrane-proximal self-association.
Kerry M Goodman, Svend Kjær, Fabienne Beuron, Phillip P Knowles, Agata Nawrotek, Emily M Burns, Andrew G Purkiss, Roger George, Massimo Santoro, Edward P Morris,[...]. Cell Rep 2014
41
31

Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.
Alexander Drilon, Zishuo I Hu, Gillianne G Y Lai, Daniel S W Tan. Nat Rev Clin Oncol 2018
134
13


Precision Targeted Therapy with BLU-667 for RET-Driven Cancers.
Vivek Subbiah, Justin F Gainor, Rami Rahal, Jason D Brubaker, Joseph L Kim, Michelle Maynard, Wei Hu, Qiongfang Cao, Michael P Sheets, Douglas Wilson,[...]. Cancer Discov 2018
195
13

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
H Donis-Keller, S Dou, D Chi, K M Carlson, K Toshima, T C Lairmore, J R Howe, J F Moley, P Goodfellow, S A Wells. Hum Mol Genet 1993
12

Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis.
E de Graaff, S Srinivas, C Kilkenny, V D'Agati, B S Mankoo, F Costantini, V Pachnis. Genes Dev 2001
178
12

RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation.
P Ballerini, S Struski, C Cresson, N Prade, S Toujani, C Deswarte, S Dobbelstein, A Petit, H Lapillonne, E-F Gautier,[...]. Leukemia 2012
65
18


State-of-the-Art Strategies for Targeting RET-Dependent Cancers.
Vivek Subbiah, Dong Yang, Vamsidhar Velcheti, Alexander Drilon, Funda Meric-Bernstam. J Clin Oncol 2020
76
15

Mutations of the RET proto-oncogene in Hirschsprung's disease.
P Edery, S Lyonnet, L M Mulligan, A Pelet, E Dow, L Abel, S Holder, C Nihoul-Fékété, B A Ponder, A Munnich. Nature 1994
646
11

RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose.
Kiyohiro Hamatani, Hidetaka Eguchi, Reiko Ito, Mayumi Mukai, Keiko Takahashi, Masataka Taga, Kazue Imai, John Cologne, Midori Soda, Koji Arihiro,[...]. Cancer Res 2008
112
11

Hirschsprung disease, associated syndromes and genetics: a review.
J Amiel, E Sproat-Emison, M Garcia-Barcelo, F Lantieri, G Burzynski, S Borrego, A Pelet, S Arnold, X Miao, P Griseri,[...]. J Med Genet 2008
560
11

Regulation of cell fate decision of undifferentiated spermatogonia by GDNF.
X Meng, M Lindahl, M E Hyvönen, M Parvinen, D G de Rooij, M W Hess, A Raatikainen-Ahokas, K Sainio, H Rauvala, M Lakso,[...]. Science 2000
949
11

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B.
M Santoro, F Carlomagno, A Romano, D P Bottaro, N A Dathan, M Grieco, A Fusco, G Vecchio, B Matoskova, M H Kraus. Science 1995
703
11

Neurturin, a relative of glial-cell-line-derived neurotrophic factor.
P T Kotzbauer, P A Lampe, R O Heuckeroth, J P Golden, D J Creedon, E M Johnson, J Milbrandt. Nature 1996
600
11

Persephin, a novel neurotrophic factor related to GDNF and neurturin.
J Milbrandt, F J de Sauvage, T J Fahrner, R H Baloh, M L Leitner, M G Tansey, P A Lampe, R O Heuckeroth, P T Kotzbauer, K S Simburger,[...]. Neuron 1998
397
11


Central role of RET in thyroid cancer.
Massimo Santoro, Francesca Carlomagno. Cold Spring Harb Perspect Biol 2013
67
16

Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers.
Julio C Ricarte-Filho, Sheng Li, Maria E R Garcia-Rendueles, Cristina Montero-Conde, Francesca Voza, Jeffrey A Knauf, Adriana Heguy, Agnes Viale, Tetyana Bogdanova, Geraldine A Thomas,[...]. J Clin Invest 2013
144
11

GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates.
Shannon E Mullican, Xiefan Lin-Schmidt, Chen-Ni Chin, Jose A Chavez, Jennifer L Furman, Anthony A Armstrong, Stephen C Beck, Victoria J South, Thai Q Dinh, Tanesha D Cash-Mason,[...]. Nat Med 2017
306
11

GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand.
Linda Yang, Chih-Chuan Chang, Zhe Sun, Dennis Madsen, Haisun Zhu, Søren B Padkjær, Xiaoai Wu, Tao Huang, Karin Hultman, Sarah J Paulsen,[...]. Nat Med 2017
269
11

RET rearrangements are actionable alterations in breast cancer.
Bhavna S Paratala, Jon H Chung, Casey B Williams, Bahar Yilmazel, Whitney Petrosky, Kirstin Williams, Alexa B Schrock, Laurie M Gay, Ellen Lee, Sonia C Dolfi,[...]. Nat Commun 2018
52
21

Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas.
Alexander Drilon, Lu Wang, Adnan Hasanovic, Yoshiyuki Suehara, Doron Lipson, Phil Stephens, Jeffrey Ross, Vincent Miller, Michelle Ginsberg, Maureen F Zakowski,[...]. Cancer Discov 2013
347
10

RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer.
Rui Wang, Haichuan Hu, Yunjian Pan, Yuan Li, Ting Ye, Chenguang Li, Xiaoyang Luo, Lei Wang, Hang Li, Yang Zhang,[...]. J Clin Oncol 2012
347
10

GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors.
Andrea Morandi, Lesley-Ann Martin, Qiong Gao, Sunil Pancholi, Alan Mackay, David Robertson, Marketa Zvelebil, Mitch Dowsett, Ivan Plaza-Menacho, Clare M Isacke. Cancer Res 2013
66
15



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.